| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.287 | 2.067 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 3.287 | 2.067 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | 101 | 1.512 | 393 | 12 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.186 | 555 | -393 | -12 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | 3.087 | 493 | -393 | -12 | 0 | 0 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Amamed Epipro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 28 | 27 | 27 | 27 | 27 | 27 |
| Current Assets | - | - | - | - | 3.172 | 3.543 | 3.065 | 3.062 | 3.053 | 3.036 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 135 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 3.037 | 3.543 | 3.065 | 3.062 | 3.053 | 3.036 |
| Shareholders Funds | - | - | - | - | 3.130 | 3.563 | 3.091 | 3.089 | 3.080 | 3.062 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 70 | 7 | 0 | 0 | 0 | 0 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amamed Epipro S.r.l.